These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2783559)

  • 1. Production of interleukin 1 activity by cultured human melanoma cells.
    Bennicelli JL; Elias J; Kern J; Guerry D
    Cancer Res; 1989 Feb; 49(4):930-5. PubMed ID: 2783559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression.
    Rak JW; Hegmann EJ; Lu C; Kerbel RS
    J Cell Physiol; 1994 May; 159(2):245-55. PubMed ID: 8163565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours.
    García-Vázquez MD; Boyano MD; Cañavate ML; Gardeazabal J; de Galdeano AG; López-Michelena T; Ratón JA; Izu R; Díaz-Ramón JL; Díaz-Pérez JL
    Eur Cytokine Netw; 2000 Dec; 11(4):654-61. PubMed ID: 11125310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 production by human melanoma cell lines.
    Lee JD; Sievers TM; Skotzko M; Chandler CF; Morton DL; McBride WH; Economou JS
    Lymphokine Cytokine Res; 1992 Jun; 11(3):161-6. PubMed ID: 1391235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses.
    Elner VM; Burnstine MA; Strieter RM; Kunkel SL; Elner SG
    Exp Eye Res; 1997 Dec; 65(6):781-9. PubMed ID: 9441701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice.
    Mrowietz U; Schwenk U; Maune S; Bartels J; Küpper M; Fichtner I; Schröder JM; Schadendorf D
    Br J Cancer; 1999 Mar; 79(7-8):1025-31. PubMed ID: 10098731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of interleukin 1 by adult T cell leukemia (ATL) cell lines.
    Yamashita U; Shirakawa F; Nakamura H
    J Immunol; 1987 May; 138(10):3284-9. PubMed ID: 2883235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.
    Schadendorf D; Möller A; Algermissen B; Worm M; Sticherling M; Czarnetzki BM
    J Immunol; 1993 Sep; 151(5):2667-75. PubMed ID: 8360485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of lipoprotein lipase in 3T3-L1 cells by a mediator produced by SEKI melanoma, a cachexia-inducing human melanoma cell line.
    Kawakami M; Kondo Y; Imai Y; Hashiguchi M; Ogawa H; Hiragun A; Aotsuka S; Shibata S; Oda T; Murase T
    J Biochem; 1991 Jan; 109(1):78-82. PubMed ID: 2016276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.
    Weinreich DM; Elaraj DM; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Spiess PJ; Alexander HR
    Cancer Res; 2003 Sep; 63(18):5957-61. PubMed ID: 14522922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells.
    He YG; Mayhew E; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4240-6. PubMed ID: 15557426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
    Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
    J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression.
    Teshigawara K; Maeda M; Nishino K; Nikaido T; Uchiyama T; Tsudo M; Wano Y; Yodoi J
    J Mol Cell Immunol; 1985; 2(1):17-26. PubMed ID: 2978223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
    Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion of interleukin-6 and prostaglandin E2 during uveal melanoma-monocyte in vitro interactions.
    Cools-Lartigue J; Marshall JC; Caissie AL; Saraiva VS; Burnier MN
    Exp Eye Res; 2004 Oct; 79(4):451-4. PubMed ID: 15381029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogene.
    Castelli C; Sensi M; Lupetti R; Mortarini R; Panceri P; Anichini A; Parmiani G
    Cancer Res; 1994 Sep; 54(17):4785-90. PubMed ID: 8062279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of interleukin-8 expression in human melanoma cells by the organ environment.
    Gutman M; Singh RK; Xie K; Bucana CD; Fidler IJ
    Cancer Res; 1995 Jun; 55(11):2470-5. PubMed ID: 7758001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of interleukin-1 beta in a human keratinocyte cell line.
    McKenzie RC; Arsenault TV; Sauder DN; Harley CB
    Lymphokine Res; 1990; 9(3):391-403. PubMed ID: 2398743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity.
    Onozaki K; Matsushima K; Kleinerman ES; Saito T; Oppenheim JJ
    J Immunol; 1985 Jul; 135(1):314-20. PubMed ID: 3873493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
    Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
    Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.